Hirahara Kazuki, Liu Luzheng, Clark Rachael A, Yamanaka Kei-ichi, Fuhlbrigge Robert C, Kupper Thomas S
Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
J Immunol. 2006 Oct 1;177(7):4488-94. doi: 10.4049/jimmunol.177.7.4488.
CD4+CD25+ T regulatory cells (Treg) are thought to be important in the peripheral tolerance. Recent evidence suggests that human peripheral blood CD4+CD25+ T cells are heterogeneous and contain both CD4+CD25(high) T cells with potent regulatory activity and many more CD4+CD25(low/med) nonregulatory T cells. In this study, we found that virtually all peripheral blood CD4+CD25(high)Foxp3+ Treg expressed high levels of the chemokine receptor CCR4. In addition, 80% of Treg expressed cutaneous lymphocyte Ag (CLA) and 73% expressed CCR6. These molecules were functional, as CLA+ Treg showed CD62E ligand activity and demonstrable chemotactic responses to the CCR4 ligands CCL22 and CCL17 and to the CCR6 ligand CCL20. The phenotype and chemotactic response of these Treg were significantly different from those of CD4+CD25(med) nonregulatory T cells. We further demonstrated that blood CLA+ Treg inhibited CD4+CD25- T cell proliferation induced by anti-CD3. Based on homing receptor profile, CLA+ Treg should enter normal skin. We next isolated CD4+CD25(high) T cells directly from normal human skin; these cells suppressed proliferation of skin CD4+CD25- T cells. Therefore, the majority of true circulating Treg express functional skin-homing receptors, and human Treg may regulate local immune responses in normal human skin.
CD4+CD25+调节性T细胞(Treg)被认为在外周免疫耐受中起重要作用。最近有证据表明,人外周血CD4+CD25+ T细胞具有异质性,既包含具有强大调节活性的CD4+CD25(高)T细胞,也包含更多的CD4+CD25(低/中)非调节性T细胞。在本研究中,我们发现几乎所有外周血CD4+CD25(高)Foxp3+ Treg均高水平表达趋化因子受体CCR4。此外,80%的Treg表达皮肤淋巴细胞抗原(CLA),73%表达CCR6。这些分子具有功能,因为CLA+ Treg表现出CD62E配体活性,并对CCR4配体CCL22和CCL17以及CCR6配体CCL20表现出明显的趋化反应。这些Treg的表型和趋化反应与CD4+CD25(中)非调节性T细胞显著不同。我们进一步证明,血液中的CLA+ Treg可抑制抗CD3诱导的CD4+CD25- T细胞增殖。基于归巢受体谱,CLA+ Treg应该进入正常皮肤。接下来,我们直接从正常人皮肤中分离出CD4+CD25(高)T细胞;这些细胞可抑制皮肤CD4+CD25- T细胞的增殖。因此,大多数真正循环的Treg表达功能性皮肤归巢受体,并且人Treg可能调节正常人皮肤中的局部免疫反应。